The Research Institute at Nationwide Children's Hospital Office of Technology Commercialization presents:
Thursday, March 14, 2013
1:00 P.M. - 4:00 P.M.
The Research Institute at Nationwide Children's Hospital
575 Children's Crossroad
Research Building III, WB1110
Columbus, Ohio 43205
Please park in the Underground Garage in front of Nationwide Children's at 635 Children's Drive. Access to Children's Drive is off Parsons Ave. You will be charged $2 to park. Please cross Parsons Ave at Children's Crossroads. The entrance to Research Building III is located on the west side of the building. The 2013 Technology Showcase will provide you with a parking voucher at the event to exit the garage.
1:00-1:30 PM: Networking Reception
1:30-3:30 PM: Technology Showcase
1:30-1:35 PM: Introduction
1:35-1:55 PM: Center for Gene Therapy at The Research Institute at Nationwide Children's
1:55-2:10 PM: Novel Compositions and Methods for Removal of Biofilms
2:10-2:25 PM: Churchill: A Comprehensive Analysis Pipeline for Discovery of Human Genetic Variation
2:25-2:40 PM: Diagnostic Biomarkers for Diseases of the Urinary Tract
2:40-2:55 PM: Medical Device Innovations at Nationwide Children’s Hospital
2:55-3:00 PM: Break
3:00 to 3:30 PM: Keynote Speaker: David Scholl, PhD "Lessons learned and development strategies for researchers and life science companies."
Dr. David Scholl served as President and CEO of Diagnostic Hybrids, Inc. (DHI) in Athens, Ohio from 1995 to 2009. One of DHI’s early technology founders, Dave joined the company as Director of Research in 1983. Under his leadership, DHI grew from a four-person startup to the Inc. 500 list, emerging as a world leader in cell- and MAb-based diagnostics. The company’s dynamic growth led to its sale in February 2010 to Quidel Corporation of San Diego, California. Dave then joined the Quidel executive team as a Senior Vice President, while remaining President of DHI until his retirement in October 2011. He is now a partner with Athenian Venture Partners, a venture capital firm that makes investments in private, high growth potential, technology based companies in the Information Technology and Biomedical Sciences sphere.
Dave currently serves on the boards of the Ohio Third Frontier Commission, BioOhio, Ohio University’s Edison Biotechnology Institute and Manasseh Cutler Scholars Program, and served from 2006-2012 as president of the Foundation for Ichthyosis and Related Skin Types (FIRST). He is also a trustee of Ohio University and the Ohio University Foundation.
Dave has nearly 30 years of life sciences experience in research and development, executive management and venture capital. In 2003, he was the recipient of the Central Ohio Ernst and Young Entrepreneur of the Year Award in Life Sciences, in 2006 was awarded BioOhio's Bioscience Leadership Award, and in 2010, Dave was awarded The Phillips Medal of Public Service by the Ohio University Heritage College of Osteopathic Medicine, and in 2013 named an inaugural recipient of The Konneker Medal for Innovation and Entrepreneurship by Ohio University.
3:30-4:00 PM: Networking Reception
Tours of The Research Institute's new Research Building III available
For more information about the 2013 Technology Showcase, please contact the Office of Technology Commercialization at Tech.Commercialization@NationwideChildrens.org or (614) 355-2818.